Insider Trading History of Rozenman Mary M.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Rozenman Mary M. since 2016. The trader's CIK number is 1648920. At the time of the last reporting, Rozenman Mary M. was the See Remarks of Aimmune Therapeutics, Inc.. (stock ticker symbol AIMT). Also see all insider trading activities at Aimmune Therapeutics, Inc..


Yearly summary of insider trading at Aimmune Therapeutics, Inc. (AIMT) by Rozenman Mary M.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 AIMT 0 $0 14,990 $536,797 14,990 $45,299
2017 AIMT 0 $0 165,010 $4,861,612 165,010 $498,658
2016 AIMT 0 $0 79,096 $1,348,089 79,096 $239,028


Insider trading of Aimmune Therapeutics, Inc. (AIMT) by Rozenman Mary M.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-03-01 AIMT Option Ex 1,807 3.02 5,460
2018-03-01 AIMT Sale 1,807 33.10 59,811
2018-02-01 AIMT Sale 6,592 35.26 232,460
2018-02-01 AIMT Option Ex 6,592 3.02 19,921
2018-01-02 AIMT Option Ex 6,591 3.02 19,918
2018-01-02 AIMT Sale 6,591 37.10 244,526
2017-12-26 AIMT Sale 75,010 39.02 2,926,965
2017-12-26 AIMT Option Ex 75,010 3.02 226,680
2017-09-07 AIMT Option Ex 30,000 3.02 90,660
2017-09-07 AIMT Sale 30,000 22.50 675,000
2017-07-17 AIMT Sale 300 21.38 6,414
2017-07-13 AIMT Option Ex 8,974 3.02 27,119
2017-07-14 AIMT Option Ex 5,666 3.02 17,122
2017-07-13 AIMT Sale 8,974 21.47 192,662
2017-07-14 AIMT Sale 5,666 21.39 121,173
2017-07-17 AIMT Option Ex 300 3.02 906
2017-07-05 AIMT Option Ex 15,060 3.02 45,511
2017-07-03 AIMT Sale 30,000 20.57 617,190
2017-07-03 AIMT Option Ex 30,000 3.02 90,660
2017-07-05 AIMT Sale 15,060 21.39 322,208
2016-11-04 AIMT Sale 24,096 17.60 424,089
2016-11-04 AIMT Option Ex 24,096 3.02 72,818
2016-10-05 AIMT Option Ex 25,000 3.02 75,550
2016-10-05 AIMT Sale 25,000 16.80 420,000
2016-09-08 AIMT Sale 30,000 16.80 504,000
2016-09-08 AIMT Option Ex 30,000 3.02 90,660

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rozenman Mary M. (See Remarks of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.